Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 25, 2012Expert Opinion on Emerging Drugs

Recent developments on immunotherapy for brain cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

DWDerek A. WainwrightLoyola University ChicagoPNPragati NigamUniversity of ChicagoBTBart ThaçiUniversity of Pittsburgh Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wainwright et al. (2012) studied this question.

synapsesocial.com/papers/6a105175d478ddac0ffcb165https://doi.org/10.1517/14728214.2012.679929
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Agonist Anti-GITR Monoclonal Antibody Induces Melanoma Tumor Immunity in Mice by Altering Regulatory T Cell Stability and Intra-Tumor Accumulation2010 · 256 citations
  2. 2Endothelial/Pericyte Interactions2005 · 2,068 citations
  3. 3Toxicologic Pathology of Cytokines, Cytokine Receptors, and Other Recombinant Human Proteins1999 · 42 citations
  4. 4Dendritic Cells, Indoleamine 2,3 Dioxygenase and Acquired Immune Privilege2010 · 117 citations